Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04958785
Title Study to Evaluate the Safety and Efficacy of Magrolimab in Combination With Nab-Paclitaxel or Paclitaxel Versus Nab-Paclitaxel or Paclitaxel in Previously Untreated Adults With Metastatic Triple-Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gilead Sciences
Indications

triple-receptor negative breast cancer

Therapies

Hu5F9-G4 + Nab-paclitaxel

Hu5F9-G4 + Sacituzumab govitecan-hziy

Nab-paclitaxel

Paclitaxel

Hu5F9-G4 + Paclitaxel

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.